AVEO Oncology
AVEO
#7408
Rank
โ‚น48.64 B
Marketcap
โ‚น1,399
Share price
0.00%
Change (1 day)
185.42%
Change (1 year)

EPS for AVEO Oncology (AVEO)

EPS in 2022 (TTM): -โ‚น64.68

According to AVEO Oncology 's latest financial reports the company's current EPS (TTM) is -โ‚น78.36. In 2021 the company made an earnings per share (EPS) of -โ‚น160.44 a decrease over its 2020 EPS that were of -โ‚น159.51.

EPS history for AVEO Oncology from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-โ‚น64.68-59.69%
2021-โ‚น160.440.58%
2020-โ‚น159.51-375.81%
2019โ‚น57.83-224%
2018-โ‚น46.64-91.8%
2017-โ‚น569.0152.5%
2016-โ‚น373.12
2014-โ‚น951.46
2012-โ‚น2,453

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eli Lilly
LLY
โ‚น2,881-3,777.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,621-2,169.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น220.14-380.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น4,382-5,692.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น421.63-638.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚น1,293-1,750.00%๐Ÿ‡บ๐Ÿ‡ธ USA